TransCode Therapeutics, Inc. (RNAZ) vs Tenon Medical, Inc. (TNON)
A side-by-side comparison of TransCode Therapeutics, Inc. and Tenon Medical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
RNAZ
TransCode Therapeutics, Inc.
$1.73HealthcareDelayed quote: Oct 6, 2026, 2:42 PM EDT
TNON
Tenon Medical, Inc.
$3.69HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT
Total return — RNAZ vs TNON
growth of $100 · dividends reinvested · last 4yRNAZ -100.0% (-96.7%/yr)TNON -100.0% (-91.2%/yr)TNON compounded faster over this window
Log scale — wide-divergence pair
RNAZ TNON
RNAZ vs TNON: by the numbers
- •TNON is the larger company ($2M vs $2M market cap).
- •Both run net losses; RNAZ's is the smaller (0.00% vs -256.33% net margin).
Metrics side by side
Valuation
| Metric | RNAZ | TNON |
|---|---|---|
| P/S ratio | N/A | 0.34 |
Profitability
| Metric | RNAZ | TNON |
|---|---|---|
| Gross margin | 0.00% | 66.25% |
| Operating margin | 0.00% | -324.34% |
| Net margin | 0.00% | -256.33% |
| ROE | -30.92% | N/A |
| ROIC | -23.73% | -217.28% |
Growth (annualized)
| Metric | RNAZ | TNON |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 150.91% |
| Total return CAGR (5Y) | -93.39% | N/A |
Go deeper
Dig into the metrics
TransCode Therapeutics ROETenon Medical ROETransCode Therapeutics operating marginTenon Medical operating marginTransCode Therapeutics revenue growthTenon Medical revenue growthTransCode Therapeutics free cash flowTenon Medical free cash flow
TransCode Therapeutics & Tenon Medical appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.